Literature DB >> 9714152

Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency.

T Moos1, P S Oates, E H Morgan.   

Abstract

In order to characterize the mechanism by which Iron (Fe) is taken up by neurons, we examined the neuronal expression of transferrin receptor (TR) in rats during development and iron (Fe) deficiency by using immunohistochemistry, in vitro receptor autoradiography and in situ hybridization. In contrast to the continuous expression of TR in brain capillary endothelial cells regardless of the age of the animals studied, the expression of neuronal TR was almost absent at late embryonic and early postnatal ages but increased with increasing age to reach a plateau from postnatal (P) 21 through adulthood as verified by immunohistochemical staining. Reducing the Fe stores potentiated the expression of TR immunoreactivity in neurons of both young and adult rats in several grey matter regions. Increased TR immunoreactivity was also observed in neuronal extensions of neurons of the medial habenular nucleus, reticular neurons of the brainstem, and fibers projecting to the area postrema. TR immunoreactivity was never observed in white matter regions, except for that recorded in brain capillaries. In vitro receptor autoradiography verified the increased capacity for transferrin binding during Fe deficiency. By contrast, TR mRNA expression was not affected by Fe deficiency. These findings demonstrate that the expression of the neuronal TR protein is age dependent and susceptible to Fe deficiency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714152

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  21 in total

1.  Deferoxamine attenuates iron-induced long-term neurotoxicity in rats with traumatic brain injury.

Authors:  Lijun Zhang; Rong Hu; Mei Li; Fei Li; Hui Meng; Gang Zhu; Jiangkai Lin; Hua Feng
Journal:  Neurol Sci       Date:  2012-04-27       Impact factor: 3.307

Review 2.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

3.  Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Authors:  Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz
Journal:  Neurobiol Dis       Date:  2013-10-08       Impact factor: 5.996

Review 4.  Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus.

Authors:  M B H Youdim
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

Review 5.  Influence of iron metabolism on manganese transport and toxicity.

Authors:  Qi Ye; Jo Eun Park; Kuljeet Gugnani; Swati Betharia; Alejandro Pino-Figueroa; Jonghan Kim
Journal:  Metallomics       Date:  2017-08-16       Impact factor: 4.526

6.  Expression of Iron-Related Proteins at the Neurovascular Unit Supports Reduction and Reoxidation of Iron for Transport Through the Blood-Brain Barrier.

Authors:  Annette Burkhart; Tina Skjørringe; Kasper Bendix Johnsen; Piotr Siupka; Louiza Bohn Thomsen; Morten Schallburg Nielsen; Lars Lykke Thomsen; Torben Moos
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

Review 7.  Brain iron metabolism and its perturbation in neurological diseases.

Authors:  Robert R Crichton; David T Dexter; Roberta J Ward
Journal:  J Neural Transm (Vienna)       Date:  2010-09-01       Impact factor: 3.575

8.  mRNA expression of proteins involved in iron homeostasis in brain regions is altered by age and by iron overloading in the neonatal period.

Authors:  Arethuza S Dornelles; Vanessa A Garcia; Maria N M de Lima; Gustavo Vedana; Luisa A Alcalde; Maurício R Bogo; Nadja Schröder
Journal:  Neurochem Res       Date:  2009-11-27       Impact factor: 3.996

9.  Increased hippocampal expression of the divalent metal transporter 1 (DMT1) mRNA variants 1B and +IRE and DMT1 protein after NMDA-receptor stimulation or spatial memory training.

Authors:  Paola Haeger; Alvaro Alvarez; Nancy Leal; Tatiana Adasme; Marco Tulio Núñez; Cecilia Hidalgo
Journal:  Neurotox Res       Date:  2009-08-05       Impact factor: 3.911

Review 10.  Role of iron in neurodegenerative diseases.

Authors:  Kai Li; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2016-01-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.